GCM
ZYME icon

Gladius Capital Management’s Zymeworks ZYME Stock Holding History

Gladius Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,189
Closed -$33.5K – 378
2024
Q1 		$33.5K Sell
3,189
-1,302
-29% -$14.5K 0.01% 278
2023
Q4 		$46.7K Buy
4,491
+551
+14% +$4.39K 0.01% 183
2023
Q3 		$25K Buy
3,940
+1,053
+36% +$7.78K ﹤0.01% 330
2023
Q2 		$24.9K Buy
+2,887
New +$25.8K ﹤0.01% 287

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Gladius Capital Management's ZYME Position: Q2 2024 in Review

Gladius Capital Management sold out of Zymeworks (ZYME) in Q2 2024, closing a stake of 3,189 shares — an estimated $33.5K sold.

Gladius Capital Management first reported a position in ZYME in Q2 2023 and held it in 4 quarters. The position peaked at $46.7K in Q4 2023. 164 funds tracked by Wall St. Rank hold ZYME as of Q2 2024.

  • Gladius Capital Management reported no remaining Zymeworks position as of Q2 2024 after selling out during the quarter.
  • Gladius Capital Management sold 3,189 Zymeworks shares in Q2 2024, an estimated $33.5K.
  • Gladius Capital Management first reported a position in Zymeworks in Q2 2023 and held it in 4 quarters.
  • Gladius Capital Management's Zymeworks position peaked at $46.7K in Q4 2023.
  • 164 funds tracked by Wall St. Rank held Zymeworks as of Q2 2024.

Based on Gladius Capital Management's 13F filing for Q2 2024, filed 18 Jul 2024.